Setting up a practice

Description: 
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source: 
PCSS
0
Your rating: None
Description: 
This consent form -- reproduced with permission from the Boston Medical Center -- can be used with your pregnant patients who want to continue taking buprenorphine during pregnancy.
Source: 
Boston Medical Center
4
Your rating: None Average: 4 (1 vote)
Description: 
This SAMHSA guideline provides information on buprenorphine treatment for nurses and other clinical support staff who assist with buprenorphine induction and maintenance.
Source: 
SAMHSA
0
Your rating: None
Description: 
This webinar, presented by Cathy A. Gallagher, Associate Chief, Liaison and Policy Section of the DEA, explains rules and regulations regarding DEA requirements for buprenorphine treatment providers.
Source: 
PCSS-Buprenorphine
5
Your rating: None Average: 5 (1 vote)
Description: 
This patient consent form (in Word®) explains buprenorphine treatment and warns about the adverse effects of mixing buprenorphine with other medications. The section at the bottom is for the patient and a witness to sign and date, indicating that the patient understands and wishes to receive treatment.
Source: 
California Society of Addiction Medicine (CSAM)
0
Your rating: None
Description: 
This chapter from TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs discusses the use of drug testing as a means of monitoring patient progress and treatment efficacy. This chapter details several methods for implementing drug testing, their effectiveness, and their pros and cons.
Source: 
Center for Substance Abuse Treatment (CSAT)
0
Your rating: None
Description: 
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
0
Your rating: None
Description: 
The California Society of Addiction Medicine (CSAM) website provides information and materials for buprenorphine treatment providers, including screening tools and sample consent and patient agreement forms, and provides links to other helpful resources.
Source: 
California Society of Addiction Medicine (CSAM)
0
Your rating: None
Description: 
PCSS-B is a free mentoring service funded by SAMHSA and coordinated by ASAM. The PCSS-B can match you with a physician mentor from your local area with whom you can discuss practice and treatment issues with him/her.
Source: 
Physician Clinical Support System (PCSS)
0
Your rating: None
Syndicate content